LL-37
Antimicrobial
The body's broad spectrum antimicrobial peptide.
Research chemical vendors can't legally label products with the real name, so LL-37 often appears under coded SKUs. If you're shopping and see any of these, it's the same compound:
- LL37
- Cathelicidin
Codes shown are for identification only. Always verify third-party COAs before purchase.
The active C terminal fragment of human cathelicidin. Disrupts bacterial, viral, and fungal membranes and modulates the innate immune response. Levels are often low in chronic infection.
- Chronic biofilm infections that don't clear with antibiotics
- Lyme, mold illness, and stealth pathogen protocols
- Acne and resistant skin infections
Educational only · Not a vendor claim
Active fragment of human cathelicidin — disrupts microbial membranes and tunes innate immunity.
- Broad antimicrobial effect
- Biofilm disruption
- Modulates innate immunity
- Symptom improvement in chronic infection
- Reduced skin breakouts
- Energy lift in stealth infection cases
- Works where antibiotics fail
- Active vs. bacteria, viruses, fungi
- Strong biofilm activity
- Herxheimer style flares possible
- Cycling required
- Not for autoimmune dominance
- Die off symptoms early on
- Headache and fatigue
- Mild injection site irritation
Educational summary · Not medical advice · Discuss with a qualified clinician
Typical timeline
General pattern for the Immunity category. Individual response varies.
- Week 1Subtle. Sleep may improve as inflammation drops.
- Weeks 2–4Fewer minor infections, better recovery from training or travel stress.
- Post-cycleBenefits carry for weeks. Bioregulator-style cycles (20–30 days on, then off) are typical.
Pairs well with
Common combinations experienced users run alongside LL-37. Always add one peptide at a time so you can attribute effects and side effects.
Read the safety guide before stacking.
The reconstitution math
- 1Reconstitute the 10 mg vial with 4 mL of bacteriostatic water. Tilt — don't shake.
- 2Concentration becomes 2,500 mcg/mL (2.5 mg/mL).
- 3For a 125 mcg dose, draw 0.050 mL — that's 5 units on a 1 mL insulin syringe.
- 4One vial gives you approximately 80 doses.
Reminder: 100 units on an insulin syringe = 1 mL. Always start at half the listed dose for the first week and rotate injection sites between arms, legs, abdomen, and glutes.
Sign in to keep a private log of your doses and notes for LL-37.
Use code ANYPEPTIDES15 for 15% off your order.
Discount may end or change without notice.